Cargando…

A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating Agents

INTRODUCTION: To evaluate the effect of early chelation therapy (≤ 3 years) with a variety of chelating agents on age at menarche and menstrual characteristics in patients with transfusion-dependent thalassemia (TDT). DESIGN: A retrospective multicenter study promoted by the International Network of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Maio, Salvatore, Marzuillo, Pierluigi, Daar, Shahina, Kattamis, Christos, Karimi, Mehran, Forough, Saki, Banchev, Atanas, Kaleva, Valeria, Christou, Soteroula, Fortugno, Carmelo, Delaporta, Polyxeni, Soliman, Ashraf T., Tzoulis, Ploutarchos, de Sanctis, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631706/ https://www.ncbi.nlm.nih.gov/pubmed/38028391 http://dx.doi.org/10.4084/MJHID.2023.058

Ejemplares similares

Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescence Medicine)
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023)

Prevalence of glucose dysregulation (GD) in patients with β-thalassemias in different countries: A preliminary ICET-A survey
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Pancreatic changes affecting glucose homeostasis in transfusion dependent β-thalassemia (TDT): a short review
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Longitudinal study of ICET-A on glucose tolerance, insulin sensitivity and β-cell secretion in eleven β-thalassemia major patients with mild iron overload
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

A Retrospective Long-Term Study on Age at Menarche and Menstrual Characteristics in 85 Young Women with Transfusion-Dependent β-Thalassemia (TDT)
por: Di Maio, Salvatore, et al.
Publicado: (2021)

Evolution of glucose-insulin homeostasis in children with β- thalassemia major (β -TM): A twenty-year retrospective ICET- A observational analysis from early childhood to young adulthood
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

An ICET- A survey on hypoparathyroidism in patients with thalassaemia major and intermedia: a preliminary report
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Long-Term Follow-up of β-Transfusion-Dependent Thalassemia (TDT) Normoglycemic Patients with Reduced Insulin Secretion to Oral Glucose Tolerance Test (OGTT): A Pilot Study
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Retrospective study on long-term effects of hormone replacement therapy (HRT) and iron chelation therapy on glucose homeostasis and insulin secretion in female ß- thalassemia major (β-TM) patients with acquired hypogonadotropic- hypogonadism (AHH)
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Glucose Homeostasis and Assessment of β-Cell Function by 3-hour Oral Glucose Tolerance (OGTT) in Patients with β-Thalassemia Major with Serum Ferritin below 1,000 ng/dL: Results from a Single ICET-A Centre
por: de Sanctis, Vincenzo, et al.
Publicado: (2023)

Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis
por: De Sanctis, Vincenzo, et al.
Publicado: (2021)

A study of isolated hyperglycemia (blood glucose ≥155 mg/dL) at 1-hour of oral glucose tolerance test (OGTT) in patients with β-transfusion dependent thalassemia (β-TDT) followed for 12 years
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

A Comprehensive Update of ICET-A Network on COVID-19 in Thalassemias: What We Know and Where We Stand
por: de Sanctis, Vincenzo, et al.
Publicado: (2020)

An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations
por: Vincenzo, De Sanctis, et al.
Publicado: (2018)

Clinical characteristics, biochemical parameters and insulin response to oral glucose tolerance test (OGTT) in 25 transfusion dependent β-thalassemia (TDT) patients recently diagnosed with diabetes mellitus (DM)
por: de Sanctis, Vincenzo, et al.
Publicado: (2021)

Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study
por: de Sanctis, Vincenzo, et al.
Publicado: (2020)

A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2020)

Assessment of glucose homeostasis in young adult female β-thalassemia major patients (β-TM) with acquired hypogonadotropic hypogonadism (AHH) never treated with sex steroids compared to eugonadal β-TM patients with spontaneous menstrual cycles
por: de Sanctis, Vincenzo, et al.
Publicado: (2023)

Hypomenorrhea in Adolescents and Youths: Normal Variant or Menstrual Disorder ? Revision of Literature and Personal Experience
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

Retrospective observational studies: Lights and shadows for medical writers
por: de Sanctis, Vincenzo, et al.
Publicado: (2022)

The effects of excess weight on glucose homeostasis in young adult females with β-thalassemia major (β-TM): A preliminary retrospective study
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Evolution of combined impaired fasting glucose and impaired glucose tolerance in β-thalassemia major: Results in 58 patients with a mean 7.7- year follow-up
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Oral glucose tolerance test: how to maximize its diagnostic value in children and adolescents
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Unilateral breast enlargement in males during adolescence (10-19 years): review of current literature and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2023)

Review and Recommendations on Management of Adult Female Thalassemia Patients with Hypogonadism based on Literature Review and Experience of ICET-A Network Specialists
por: De Sanctis, Vincenzo, et al.
Publicado: (2017)

Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

Insulin-like growth factor -1 (IGF-1) and glucose dysregulation in young adult patients with β-thalassemia major: causality or potential link?
por: De Sanctis, Vincenzo, et al.
Publicado: (2022)

The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations
por: De Sanctis, Vincenzo, et al.
Publicado: (2016)

Advances on Chelation and Chelator Metal Complexes in Medicine †
por: Kontoghiorghes, George J.
Publicado: (2020)

Chelation of cadmium.
por: Andersen, O
Publicado: (1984)

Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
por: Taher, Ali, et al.
Publicado: (2009)

Chelation in Metal Intoxication
por: Flora, Swaran J.S., et al.
Publicado: (2010)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia
por: Daar, Shahina, et al.
Publicado: (2009)

Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial
por: Avila, Maria D., et al.
Publicado: (2014)

Chelating Tendencies of Bioactive Aminophosphonates
por: Kiss, Tamas, et al.
Publicado: (1994)

Chelating agents in biological systems.
por: Schubert, J
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_ksa0iqctuf97huc956734lqtmt